Cargando…

Tenovin-6-mediated inhibition of SIRT1/2 induces apoptosis in acute lymphoblastic leukemia (ALL) cells and eliminates ALL stem/progenitor cells

BACKGROUND: Acute lymphoblastic leukemia (ALL) is a heterogeneous group of malignant disorders derived from B- or T-cell lymphoid progenitor cells. ALL often is refractory to or relapses after treatment; thus, novel targeted therapy for ALL is urgently needed. In the present study, we initially foun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Yanli, Cao, Qi, Chen, Chun, Du, Xin, Jin, Bei, Pan, Jingxuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394409/ https://www.ncbi.nlm.nih.gov/pubmed/25884180 http://dx.doi.org/10.1186/s12885-015-1282-1

Ejemplares similares

Class III-specific HDAC inhibitor Tenovin-6 induces apoptosis, suppresses migration and eliminates cancer stem cells in uveal melanoma
por: Dai, Wei, et al.
Publicado: (2016)

Metformin and tenovin‐6 synergistically induces apoptosis through LKB1‐independent SIRT1 down‐regulation in non‐small cell lung cancer cells
por: Lee, Bo Bin, et al.
Publicado: (2019)

Latest Contributions of Genomics to T-Cell Acute Lymphoblastic Leukemia (T-ALL)
por: Genescà, Eulàlia, et al.
Publicado: (2022)

Pericardial Relapse of Acute Lymphoblastic Leukemia (ALL)
por: Maslov, Diana V., et al.
Publicado: (2021)

Dysregulation of autophagy in chronic lymphocytic leukemia with the small-molecule Sirtuin inhibitor Tenovin-6
por: MacCallum, Stephanie F., et al.
Publicado: (2013)

Therapeutic Targeting of c-Myc in T-Cell Acute Lymphoblastic Leukemia (T-ALL)
por: Loosveld, Marie, et al.
Publicado: (2014)

Autophagic flux blockage by accumulation of weakly basic tenovins leads to elimination of B-Raf mutant tumour cells that survive vemurafenib
por: Ladds, Marcus J. G. W., et al.
Publicado: (2018)

Sensitivity to Pain in Children With Acute Lymphoblastic Leukemia (ALL)
por: Firoozi, Manijeh, et al.
Publicado: (2012)

ACUTE Lymphoblastic Leukemia (ALL) and COVID-19 Infection. a Campus ALL Report
por: Chiaretti, Sabina, et al.
Publicado: (2021)

Tenovin-6 impairs autophagy by inhibiting autophagic flux
por: Yuan, Hongfeng, et al.
Publicado: (2017)

Multi-Omics Analysis of Acute Lymphoblastic Leukemia Identified the Methylation and Expression Differences Between BCP-ALL and T-ALL
por: Li, Jin-Fan, et al.
Publicado: (2021)

Therapy-resistant acute lymphoblastic leukemia (ALL) cells inactivate FOXO3 to escape apoptosis induction by TRAIL and Noxa
por: Ausserlechner, Michael J., et al.
Publicado: (2013)

Changing Landscape in the Treatment of Adult Acute Lymphoblastic Leukemia (ALL)
por: Künz, Tina, et al.
Publicado: (2022)

Correction: Tenovin-6 impairs autophagy by inhibiting autophagic flux
por: Yuan, Hongfeng, et al.
Publicado: (2018)

Upregulation of T-Cell-Specific Transcription Factor Expression in Pediatric T-Cell Acute Lymphoblastic Leukemia (T-ALL)
por: Sayitoğlu, Müge, et al.
Publicado: (2012)

Use of CAR T-cell for acute lymphoblastic leukemia (ALL) treatment: a review study
por: Sheykhhasan, Mohsen, et al.
Publicado: (2022)

MD-ALL: an Integrative Platform for Molecular Diagnosis of B-cell Acute Lymphoblastic Leukemia
por: Gu, Zhaohui, et al.
Publicado: (2023)

Heterogeneous Responses of Gastric Cancer Cell Lines to Tenovin-6 and Synergistic Effect with Chloroquine
por: Ke, Xiangyu, et al.
Publicado: (2020)

Discovery and Validation of SIRT2 Inhibitors Based on Tenovin-6: Use of a (1)H-NMR Method to Assess Deacetylase Activity
por: Pirrie, Lisa, et al.
Publicado: (2012)

Cost-utility of Protocols of BFM-ALL and UK-ALL for Treatment of Children with Acute Lymphoblastic Leukemia in Iran
por: HAYATI, Hadi, et al.
Publicado: (2018)

Depletion of γ-catenin by Histone Deacetylase Inhibition Confers Elimination of CML Stem Cells in Combination with Imatinib
por: Jin, Yanli, et al.
Publicado: (2016)

FOXM1 is overexpressed in B-acute lymphoblastic leukemia (B-ALL) and its inhibition sensitizes B-ALL cells to chemotherapeutic drugs
por: CONSOLARO, FRANCESCA, et al.
Publicado: (2015)

Molecular pathway activation features of pediatric acute myeloid leukemia (AML) and acute lymphoblast leukemia (ALL) cells
por: Petrov, Ivan, et al.
Publicado: (2016)

Understanding the Roles of the Hedgehog Signaling Pathway during T-Cell Lymphopoiesis and in T-Cell Acute Lymphoblastic Leukemia (T-ALL)
por: Martelli, Alberto M., et al.
Publicado: (2023)

Tenovin-6 inhibits proliferation and survival of diffuse large B-cell lymphoma cells by blocking autophagy
por: Yuan, Hongfeng, et al.
Publicado: (2017)

FAT1 expression in T-cell acute lymphoblastic leukemia (T-ALL) modulates proliferation and WNT signaling
por: Liebig, Sven, et al.
Publicado: (2023)

Pristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-κB signaling and depleting Bcr-Abl
por: Lu, Zhongzheng, et al.
Publicado: (2010)

Protocol for isolation and analysis of the leukemia stem cells in BCR-ABL-driven chronic myelogenous leukemia mice
por: Liu, Chang, et al.
Publicado: (2023)

Correction to: Pristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-κB signaling and depleting Bcr-Abl
por: Lu, Zhongzheng, et al.
Publicado: (2021)

Progenitor of all trades
por: Van Epps, Heather L.
Publicado: (2005)

High Incidence of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia (Ph-like ALL) in Older Adults with B-ALL
por: Tasian, Sarah K, et al.
Publicado: (2016)

Rhizobium etli asparaginase II: An alternative for acute lymphoblastic leukemia (ALL) treatment
por: Huerta-Saquero, Alejandro, et al.
Publicado: (2013)

Pancytopenic Prodrome (pre-ALL) of Acute Lymphoblastic Leukemia in Adults: Possible Pathogenesis
por: Sohn, Sang Kyun, et al.
Publicado: (1998)

A murine model for human early/immature T-cell precursor acute lymphoblastic leukemia (EITP ALL)
por: Negi, Vijay, et al.
Publicado: (2022)

Overcoming apoptosis resistance in high risk acute lymphoblastic leukemia by SMAC mimetics in a preclinical ALL xenograft model in vivo
por: Schirmer, Melanie, et al.
Publicado: (2014)

Identification and targeting of treatment resistant progenitor populations in T-cell Acute Lymphoblastic Leukemia
por: Tan, Kai, et al.
Publicado: (2023)

Combination of bortezomib and daunorubicin in the induction of apoptosis in T-cell acute lymphoblastic leukemia
por: Du, Xin, et al.
Publicado: (2017)

Transcriptional Activation of Prostate Specific Homeobox Gene NKX3-1 in Subsets of T-Cell Lymphoblastic Leukemia (T-ALL)
por: Nagel, Stefan, et al.
Publicado: (2012)

The Functional Role of PRC2 in Early T-cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) – Mechanisms and Opportunities
por: Bernt, Kathrin M., et al.
Publicado: (2016)

Whole-genome DNA methylation characteristics in pediatric precursor B cell acute lymphoblastic leukemia (BCP ALL)
por: Chaber, Radosław, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_k36ltr1ov748if8lqnaqhefclv